Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

MicroRNA destabilization enables dynamic regulation of the miR-16 family in response to cell-cycle changes.

Rissland OS, Hong SJ, Bartel DP.

Mol Cell. 2011 Sep 16;43(6):993-1004. doi: 10.1016/j.molcel.2011.08.021.

2.

MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.

Xiao F, Zhang W, Chen L, Chen F, Xie H, Xing C, Yu X, Ding S, Chen K, Guo H, Cheng J, Zheng S, Zhou L.

J Transl Med. 2013 Aug 22;11:195. doi: 10.1186/1479-5876-11-195.

3.

miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes.

Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J, Xing R, Sun Z, Zheng X.

Nucleic Acids Res. 2008 Sep;36(16):5391-404. doi: 10.1093/nar/gkn522. Epub 2008 Aug 13.

4.

MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells.

Sengupta S, Nie J, Wagner RJ, Yang C, Stewart R, Thomson JA.

Stem Cells. 2009 Jul;27(7):1524-8. doi: 10.1002/stem.84.

5.

The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition.

Cloonan N, Brown MK, Steptoe AL, Wani S, Chan WL, Forrest AR, Kolle G, Gabrielli B, Grimmond SM.

Genome Biol. 2008;9(8):R127. doi: 10.1186/gb-2008-9-8-r127. Epub 2008 Aug 14.

6.

Continuous ERK activation downregulates antiproliferative genes throughout G1 phase to allow cell-cycle progression.

Yamamoto T, Ebisuya M, Ashida F, Okamoto K, Yonehara S, Nishida E.

Curr Biol. 2006 Jun 20;16(12):1171-82.

7.

MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes.

Inomata M, Tagawa H, Guo YM, Kameoka Y, Takahashi N, Sawada K.

Blood. 2009 Jan 8;113(2):396-402. doi: 10.1182/blood-2008-07-163907. Epub 2008 Oct 21. Erratum in: Blood. 2009 May 21;113(21):5368.

8.

Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.

Georges SA, Biery MC, Kim SY, Schelter JM, Guo J, Chang AN, Jackson AL, Carleton MO, Linsley PS, Cleary MA, Chau BN.

Cancer Res. 2008 Dec 15;68(24):10105-12. doi: 10.1158/0008-5472.CAN-08-1846.

9.

MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells.

Xia H, Qi Y, Ng SS, Chen X, Chen S, Fang M, Li D, Zhao Y, Ge R, Li G, Chen Y, He ML, Kung HF, Lai L, Lin MC.

Biochem Biophys Res Commun. 2009 Mar 6;380(2):205-10. doi: 10.1016/j.bbrc.2008.12.169. Epub 2009 Jan 9.

PMID:
19135980
10.

miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression.

Pickering MT, Stadler BM, Kowalik TF.

Oncogene. 2009 Jan 8;28(1):140-5. doi: 10.1038/onc.2008.372. Epub 2008 Oct 6.

11.

Genome-wide identification of translationally inhibited and degraded miR-155 targets using RNA-interacting protein-IP.

Meier J, Hovestadt V, Zapatka M, Pscherer A, Lichter P, Seiffert M.

RNA Biol. 2013 Jun;10(6):1018-29. doi: 10.4161/rna.24553. Epub 2013 Apr 15.

12.

Gap Junctions Enhance the Antiproliferative Effect of MicroRNA-124-3p in Glioblastoma Cells.

Suzhi Z, Liang T, Yuexia P, Lucy L, Xiaoting H, Yuan Z, Qin W.

J Cell Physiol. 2015 Oct;230(10):2476-88. doi: 10.1002/jcp.24982.

PMID:
25753094
13.

MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.

Janaki Ramaiah M, Lavanya A, Honarpisheh M, Zarea M, Bhadra U, Bhadra MP.

Gene. 2014 Dec 1;552(2):255-64. doi: 10.1016/j.gene.2014.09.052. Epub 2014 Sep 26.

PMID:
25261849
14.

MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma.

Lin J, Huang S, Wu S, Ding J, Zhao Y, Liang L, Tian Q, Zha R, Zhan R, He X.

Carcinogenesis. 2011 Nov;32(11):1641-7. doi: 10.1093/carcin/bgr199. Epub 2011 Sep 1.

PMID:
21890460
15.

mir-35 is involved in intestine cell G1/S transition and germ cell proliferation in C. elegans.

Liu M, Liu P, Zhang L, Cai Q, Gao G, Zhang W, Zhu Z, Liu D, Fan Q.

Cell Res. 2011 Nov;21(11):1605-18. doi: 10.1038/cr.2011.102. Epub 2011 Jun 21.

16.

Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma.

Zhao C, Zhang J, Zhang S, Yu D, Chen Y, Liu Q, Shi M, Ni C, Zhu M.

Oncol Rep. 2013 Jul;30(1):276-84. doi: 10.3892/or.2013.2420. Epub 2013 Apr 23.

PMID:
23612862
17.

MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.

Hui W, Yuntao L, Lun L, WenSheng L, ChaoFeng L, HaiYong H, Yueyang B.

PLoS One. 2013;8(1):e54932. doi: 10.1371/journal.pone.0054932. Epub 2013 Jan 28.

19.

Transcriptional repression of miR-34 family contributes to p63-mediated cell cycle progression in epidermal cells.

Antonini D, Russo MT, De Rosa L, Gorrese M, Del Vecchio L, Missero C.

J Invest Dermatol. 2010 May;130(5):1249-57. doi: 10.1038/jid.2009.438. Epub 2010 Jan 21.

20.

MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways.

Lin SL, Chang DC, Ying SY, Leu D, Wu DT.

Cancer Res. 2010 Nov 15;70(22):9473-82. doi: 10.1158/0008-5472.CAN-10-2746. Epub 2010 Nov 9.

Supplemental Content

Support Center